Glaucoma, Neovascular - 24 Studies Found
| Completed |
: Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma : Glaucoma, Neovascular : 2013-08-04 : Drug: intravitreal ranibizumab The patients received IVR (0.5 mg in 0.05 ml) injection through the pars |
| Completed |
: Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients : Glaucoma, Neovascular : 2015-03-18 :
|
| Withdrawn |
: Effects of Travoprost on Neovascular Glaucoma : Neovascular Glaucoma : 2007-02-27 : Drug: Travoprost |
| Not yet recruiting |
: Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study :
: 2016-09-22 : Drug: Intravitreal ranibizumab Intravitreal ranibizumab injection |
| Not yet recruiting |
: Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma : Neovascular Glaucoma : 2014-07-17 : Procedure: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 Surgically Implant an Ahm |
| Completed |
: Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma : Neovascular Glaucoma : 2010-01-07 : Procedure: Diode laser cyclophotocoagulation enhanced by intravitreal injection of Avastin The operative |
| Completed |
: Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma : Neovascular Glaucoma : 2012-10-18 : Drug: Aflibercept Details covered in arm description |
| Recruiting |
: The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma : Neovascular Glaucoma : 2017-05-07 :
|
| Completed |
: Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma :
: 2011-05-27 : Drug: 0.5mg intraocular Ranibizumab (Lucentis) short- and long-term effects of 0.5mg intraocular Ranibiz |
| Withdrawn |
: Lucentis for New Onset Neovascular Glaucoma :
|